BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20260630T103000
DTEND;TZID=Europe/Amsterdam:20260630T123000
DTSTAMP:20260625T101523
CREATED:20260622T145259Z
LAST-MODIFIED:20260622T145259Z
UID:19454-1782815400-1782822600@remedi4all.org
SUMMARY:BioMed21 Webinar: Rare Disease Research and Drug Development with NAMs in the EU
DESCRIPTION:Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation \nWebinar description \nBioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar exploring how New Approach Methodologies (NAMs)\, including advanced human-relevant in vitro models and in silico technologies\, are transforming rare disease research and drug development. \nThe webinar will bring together experts from academia\, policy\, and biomedical research to discuss innovative approaches ranging from retinal organoids and retina-on-chip systems to computational modelling and AI-driven strategies for therapy development. \nTopics will include: \n\nHuman-centric strategies for rare disease research\nhiPSC-derived organoids and organ-on-chip technologies\nIn silico modelling and computational approaches\nTranslational opportunities and challenges for NAMs in therapy development\nEuropean research and policy perspectives\n\nDraft agenda \n\nAdvancing Human-Centric Strategies for Rare Disease Research: A European Research Policy Perspective\nFrancesca Pistollato – Humane World for Animals\nHuman retinal organoids and retina-chip platform for modeling disease and gene therapy\nKevin Achberger – University of Tübingen\nHuman-Centric In Silico Modeling for Rare Disease Research and Drug Development\nFrancesco Pappalardo – University of Catania & the COMBINE Group\nNAMs in Rare Disease Therapy Development: Where and When Do They Fit?\nManoe Janssen – Radboudumc\n\n📄 BioMed21 Policy Paper: https://biomed21.org/wp-content/uploads/2026/05/RareDiseases_WhitePaper_2026-final.pdf \n\n\n\nRegister for the webinar here!
URL:https://remedi4all.org/event/biomed21-webinar-rare-disease-research-and-drug-development-with-nams-in-the-eu/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2026/06/Diseno-sin-titulo-e1781530718337.png
END:VEVENT
END:VCALENDAR